Retrovirally Mediated Expression of Decorin by Macrovascular Endothelial Cells

Decorin is a member of the widely expressed family of small leucine-rich proteoglycans. In addition to a primary role as a modulator of extracellular matrix protein fibrillogenesis, decorin can inhibit the cellular response to growth factors. Decorin expression is induced in endothelial cells during angiogenesis, but not when migration and proliferation are stimulated. Thus, decorin may support the formation of the fibrillar pericellular matrix that stabilizes the differentiated endothelial phenotype during the later stages of angiogenesis. Therefore, we tested whether constitutive decorin expression alone could modify endothelial cell migration and proliferation or affect pericellular matrix formation. To this end, replication-defective retroviral vectors were used to stably express bovine decorin, which was detected by Northern and Western blotting. The migration of endothelial cells that express decorin is significantly inhibited in both monolayer outgrowth and microchemotaxis chamber assays. The inhibition of cell migration by decorin was not accompanied by decreased proliferation. In addition, endothelial cells that express decorin assemble an extensive fibrillar fibronectin matrix more rapidly than control cells as assessed by immunocytochemical and fibronectin fibrillogenesis assays. These observations suggest that cell migration may be modulated by the influence of decorin on the assembly of the cell-associated extracellular matrix.

[1]  N. Boudreau,et al.  Extracellular matrix and integrin signalling: the shape of things to come. , 1999, The Biochemical journal.

[2]  P. Howe,et al.  TGF‐β induces fibronectin synthesis through a c‐Jun N‐terminal kinase‐dependent, Smad4‐independent pathway , 1999, The EMBO journal.

[3]  R. Iozzo,et al.  Decorin Is a Biological Ligand for the Epidermal Growth Factor Receptor* , 1999, The Journal of Biological Chemistry.

[4]  M. Pepper,et al.  Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. , 1999, Journal of cell science.

[5]  J. Schittny,et al.  Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. , 1999, European journal of cell biology.

[6]  E. Schönherr,et al.  Decorin core protein fragment Leu155-Val260 interacts with TGF-beta but does not compete for decorin binding to type I collagen. , 1998, Archives of biochemistry and biophysics.

[7]  K. Hirschi,et al.  PDGF, TGF-β, and Heterotypic Cell–Cell Interactions Mediate Endothelial Cell–induced Recruitment of 10T1/2 Cells and Their Differentiation to a Smooth Muscle Fate , 1998, The Journal of cell biology.

[8]  M. Neeman,et al.  Intercellular communication between vascular smooth muscle and endothelial cells mediated by heparin‐binding epidermal growth factor‐like growth factor and vascular endothelial growth factor , 1998, FEBS letters.

[9]  T. Shinomura,et al.  Leucine-rich repeat glycoproteins of the extracellular matrix. , 1998, Matrix biology : journal of the International Society for Matrix Biology.

[10]  K. O. Mercurius,et al.  Inhibition of vascular smooth muscle cell growth by inhibition of fibronectin matrix assembly. , 1998, Circulation research.

[11]  D. M. Peters,et al.  Fibronectin Fibrillogenesis Involves the Heparin II Binding Domain of Fibronectin* , 1998, The Journal of Biological Chemistry.

[12]  R. Iozzo,et al.  Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. , 1998, The Journal of clinical investigation.

[13]  J. Schwarzbauer,et al.  Modulatory roles for integrin activation and the synergy site of fibronectin during matrix assembly. , 1997, Molecular biology of the cell.

[14]  M. Ferguson,et al.  Differences in the distribution of versican, decorin, and biglycan in atherosclerotic human coronary arteries. , 1997, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[15]  E. Cagliero,et al.  Cytoskeletal changes induced by excess extracellular matrix impair endothelial cell replication , 1997, Diabetologia.

[16]  B. Calabretta,et al.  Ectopic expression of decorin protein core causes a generalized growth suppression in neoplastic cells of various histogenetic origin and requires endogenous p21, an inhibitor of cyclin-dependent kinases. , 1997, The Journal of clinical investigation.

[17]  T. Yoshihara,et al.  Increased levels of alpha V-associated integrins in association with growth inhibition of cultured tumor cells by bromodeoxyuridine. , 1997, Anticancer research.

[18]  Renato V. Iozzo,et al.  Targeted Disruption of Decorin Leads to Abnormal Collagen Fibril Morphology and Skin Fragility , 1997, Journal of Cell Biology.

[19]  T. Wight,et al.  Selective Expression and Processing of Biglycan during Migration of Bovine Aortic Endothelial Cells , 1997, The Journal of Biological Chemistry.

[20]  Chuan-long Wu,et al.  Roles of integrins in fibronectin matrix assembly. , 1997, Histology and histopathology.

[21]  R. Iozzo,et al.  The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. , 1997, Critical reviews in biochemistry and molecular biology.

[22]  A. Hocking,et al.  Recombinant Decorin Glycoforms , 1996, The Journal of Biological Chemistry.

[23]  Y. Kaneda,et al.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.

[24]  D. Cheresh,et al.  Review: The Integrin αvβ3: Angiogenesis and Apoptosis , 1995 .

[25]  P. Baciu,et al.  Protein kinase C regulates the recruitment of syndecan-4 into focal contacts. , 1995, Molecular biology of the cell.

[26]  Oldberg,et al.  Decorin-binding Sites for Collagen Type I Are Mainly Located in Leucine-rich Repeats 4-5 (*) , 1995, The Journal of Biological Chemistry.

[27]  T. Rosenquist,et al.  Expression of collagens and decorin during aortic arch artery development: implications for matrix pattern formation. , 1995, Matrix biology : journal of the International Society for Matrix Biology.

[28]  R. Juliano,et al.  Integrin alpha 5 beta 1 expression negatively regulates cell growth: reversal by attachment to fibronectin. , 1995, Molecular biology of the cell.

[29]  E. Schönherr,et al.  Decorin-Type I Collagen Interaction , 1995, The Journal of Biological Chemistry.

[30]  E. Schönherr,et al.  Selective inactivity of TGF‐β/decorin complexes , 1994 .

[31]  E. Ruoslahti,et al.  Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta. , 1994, The Biochemical journal.

[32]  J. Schwarzbauer,et al.  Interactions between fibronectin and chondroitin sulfate are modulated by molecular context. , 1994, The Journal of biological chemistry.

[33]  R. Jaenisch,et al.  Fibronectin binding site in type I collagen regulates fibronectin fibril formation , 1993, The Journal of cell biology.

[34]  M. Iruela-Arispe,et al.  Expression of decorin by sprouting bovine aortic endothelial cells exhibiting angiogenesis in vitro. , 1992, Experimental cell research.

[35]  K. Vogel,et al.  The interaction of decorin core protein fragments with type I collagen. , 1992, Biochemical and biophysical research communications.

[36]  E. Qwarnstrom,et al.  The role of proteoglycans in cell adhesion, migration and proliferation. , 1992 .

[37]  H. Kresse,et al.  Interactions between thrombospondin and the small proteoglycan decorin: interference with cell attachment. , 1992, European journal of cell biology.

[38]  L. Rosenberg,et al.  Regulation of cell substrate adhesion: effects of small galactosaminoglycan-containing proteoglycans , 1992, The Journal of cell biology.

[39]  R. Timpl,et al.  Binding of the proteoglycan decorin to collagen type VI. , 1992, The Journal of biological chemistry.

[40]  A. Woods,et al.  Heparan sulfate proteoglycans and signalling in cell adhesion. , 1992, Advances in experimental medicine and biology.

[41]  L. Sandell,et al.  Differential expression of small chondroitin/dermatan sulfate proteoglycans, PG-I/biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. , 1991, The Journal of biological chemistry.

[42]  H. Kresse,et al.  Interaction of the small proteoglycan decorin with fibronectin. Involvement of the sequence NKISK of the core protein. , 1991, The Biochemical journal.

[43]  P. Bornstein,et al.  Transcriptional activity of the alpha 1(I)-collagen promoter is correlated with the formation of capillary-like structures by endothelial cells in vitro. , 1991, The Journal of biological chemistry.

[44]  Erkki Ruoslahti,et al.  Proteoglycans as modulators of growth factor activities , 1991, Cell.

[45]  H. Kresse,et al.  Influence of decorin on fibroblast adhesion to fibronectin. , 1991, European journal of cell biology.

[46]  M. Young,et al.  Expression and localization of the two small proteoglycans biglycan and decorin in developing human skeletal and non-skeletal tissues. , 1990, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[47]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[48]  E. Ruoslahti,et al.  Analysis of glycosaminoglycan substitution in decorin by site-directed mutagenesis. , 1990, The Journal of biological chemistry.

[49]  Miller Ad,et al.  Improved Retroviral Vectors for Gene Transfer and Expression , 1989 .

[50]  D. Rifkin,et al.  Inhibition of endothelial cell movement by pericytes and smooth muscle cells: activation of a latent transforming growth factor-beta 1-like molecule by plasmin during co-culture , 1989, The Journal of cell biology.

[51]  Gary R. Grotendorst,et al.  EGF and TGF‐alpha are potent chemoattractants for endothelial cells and EGF‐like peptides are present at sites of tissue regeneration , 1989, Journal of cellular physiology.

[52]  M. Young,et al.  Deduced protein sequence of bone small proteoglycan I (biglycan) shows homology with proteoglycan II (decorin) and several nonconnective tissue proteins in a variety of species. , 1989, The Journal of biological chemistry.

[53]  K. Vogel,et al.  Characteristics of the in vitro interaction of a small proteoglycan (PG II) of bovine tendon with type I collagen. , 1989, Matrix.

[54]  T. Wight,et al.  Isolation and characterization of dermatan sulfate proteoglycans synthesized by cultured bovine aortic endothelial cells. , 1988, The Journal of biological chemistry.

[55]  A. Woods,et al.  Fibronectin fibril formation involves cell interactions with two fibronectin domains. , 1988, Experimental cell research.

[56]  J. Termine,et al.  Molecular cloning and sequence analysis of the cDNA for small proteoglycan II of bovine bone. , 1987, The Biochemical journal.

[57]  A. Schmidt,et al.  Mapping of proteoglycans in human arterial tissue. , 1987, European journal of cell biology.

[58]  W. Birchmeier,et al.  Inhibitory action of transforming growth factor beta on endothelial cells. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[59]  J. Trotter,et al.  The effect of proteoglycans on the morphology of collagen fibrils formed in vitro. , 1987, Collagen and related research.

[60]  V. Nolte,et al.  Interaction of small dermatan sulfate proteoglycan from fibroblasts with fibronectin , 1987, The Journal of cell biology.

[61]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[62]  Richard O. Hynes,et al.  Integrins: A family of cell surface receptors , 1987, Cell.

[63]  S. Schwartz,et al.  Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. , 1986, Science.

[64]  W. Birchmeier,et al.  Transforming growth factor-beta inhibits endothelial cell proliferation. , 1986, Biochemical and biophysical research communications.

[65]  J. Massagué,et al.  Transforming growth factor-beta stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. , 1986, The Journal of biological chemistry.

[66]  T. Wight,et al.  Modulation of sulfated proteoglycan synthesis by bovine aortic endothelial cells during migration , 1986, The Journal of cell biology.

[67]  D. Heinegård,et al.  Specific inhibition of type I and type II collagen fibrillogenesis by the small proteoglycan of tendon. , 1984, The Biochemical journal.

[68]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[69]  S. Schwartz,et al.  Inhibition of Endotheiiai Cell Regrowth: Cessation of Aortic Endotheiiai Cell Replication after Balloon Catheter Denudation , 1982, Arteriosclerosis.

[70]  J. Scott,et al.  Dermatan sulphate-rich proteoglycan associates with rat tail-tendon collagen at the d band in the gap region. , 1981, The Biochemical journal.

[71]  S. Schwartz,et al.  Vascular wall growth control: the role of the endothelium. , 1981, Arteriosclerosis.

[72]  B. Toole,et al.  Dermatan sulfate-protein: isolation from and interaction with collagen. , 1968, Archives of biochemistry and biophysics.

[73]  B. Toole,et al.  The effect of chondroitin sulphate-protein on the formation of collagen fibrils in vitro. , 1968, The Biochemical journal.